BioDelivera入选YC
摘要
BioDelivera入选YC Fall 2026，由一对博士姐妹创办，开发可编程药物递送平台GCV，称注射疗法到达病变细胞不足3%，该平台旨在让药物集中于目标细胞。
原文片段
BioDelivera - Programmable drug delivery to enable cures for every disease 🎯 Programmable drug delivery precisely targets only diseased cells **TL;DR:** Less than 3% of an injected therapy reaches diseased cells. Therapies spread throughout the body, accumulating in healthy organs instead of target…